Free Republic

Patrick Rooney of Old School™ comments following the White House Coronavirus news briefing Sunday evening, March 29, 2019. The President extended "social distancing" guidelines until April 30th based on recommendations from his medical advisers Dr. Anthony Fauci and Dr. Deborah Birx. At the briefing, Dr. Fauci repeated this concern that 100-200,000 Americans could die from Coronavirus (COVID-19) if steps are not taken to prevent this. The President stated that the anti-malaria drug Hydrochloroquine is being tested in New York state, and that 1,100 are in a study. Governor Andrew Cuomo has given a directive that people outside the study group...

On March 19, we published a story about a trial study conducted by French researchers which showed a combination of Hydroxychloroquine (plaquenil) and Azithromycin to be effective in the treatment of COVID-19 patients. The study, which was led by renowned Didier Raoult​ M.D/Ph.D, et. al in France, showed that 100% of patients that received a combination of the two anti-malaria drugs tested negative and were virologically cured within 6 days of treatment. The first preliminary trial involved a total of 36 COVID-19 patients. However, U.S. health agencies like FDA and CDA, are still very cautious about the effectiveness and safety...

Dr. Vladimir (Zev) Zelenko Board Certified Family Practitioner 501 Rt 208, Monroe, NY 10950 845-238-0000 March 23, 2020 To all medical professionals around the world: My name is Dr. Zev Zelenko and I practice medicine in Monroe, NY. For the last 16 years, I have cared for approximately 75% of the adult population of Kiryas Joel, which is a very close knit community of approximately 35,000 people in which the infection spread rapidly and unchecked prior to the imposition of social distancing. As of today my team has tested approximately 200 people from this community for Covid-19, and 65% of...

Laurus Labs, one of the world's largest manufacturers of anti-HIV drugs on March 27, said it will supplying anti-malarial drug Hydroxychloroquine to its US partner Rising Pharma Holdings to test as a preventive treatment for novel coronavirus, or COVID-19. The company has received an approval from the US Food & Drug Administration (USFDA) to market Hydroxychloroquine Sulphate tablets. (Please see link for full story)

The controversial coronavirus drug that a Hasidic doctor has been using to treat hundreds of people with moderate symptoms in upstate N.Y. is also being tried by doctors in at least three other states, and New York health officials have started using it to treat critically ill patients in hospitals. The expansion in the use of the drug, the anti-malarial hydroxychloroquine, comes despite concern that its effectiveness in treating Covid-19 has not been tested in a controlled clinical study, and that demand for it could cause shortages that prevent access by people with other diseases who need it. Its embrace...

In a video posted on YouTube, Dr. Vladimir Zelenko said he saw the symptom of shortness of breath resolved within four to six hours, the Gateway Pundit blog reported. Zelenko, addressing his message to President Trump, said he's a board-certified family practioner in the community of Kiryas Joel in Orange County, New York, in the Hudson Valley, about 50 miles north of New York City. "I'm seeing a tremendous outbreak in this community," he said. "My estimate is more than 60% currently have the infection. "That's based on the percentage of the tests that I'm getting back already," Zelenko explained....

A doctor treating clients in a Hasidic village in upstate New York said in an interview on Tuesday that none of the roughly 500 people he has treated for coronavirus symptoms has required hospitalization. He said he has been using an experimental treatment based around a drug touted by President Trump, and Sean Hannity has discussed his work on the Fox News Channel.Dr. Vladimir Zelenko, a board-certified family practitioner who runs a family clinic near the village of Kiryas Joel, acknowledged that his regiment was new and untested, and it was too soon to assess its long-term effectiveness. But...